Century Therapeutics (IPSC) downgraded to Hold after CNTY-101 halted and slow clinical progress. Click here to read my most ...
Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results